Search - tctmd.com

Displaying 301 - 320 of 640

Sort: Relevancy | Date

Presentation TVT 2019

The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS Results

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

LAA Occlusion Plus: MitraClip, TAVR, PCI, and More

Presenter: Samir Kapadia

June 13, 2019

Presentation TVT 2019

2 Illustrative Cases – A Case-Based Discussion

Presenter: Mao Chen

June 13, 2019

Presentation TVT 2019

Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 13, 2019

Presentation TVT 2019

Which Patients Should Still Have Surgical AVR? Who Are Poor Candidates for TAVR?

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

Presenter: John Webb

June 13, 2019

Presentation TVT 2019

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Presenter: Martin Leon

June 13, 2019

Presentation TVT 2019

Does Surgical Risk Still Matter When Evaluating for TAVR?

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

The LOTUS Edge TAVR System: Clinical Trial Updates

Presenter: Chris Meduri

June 13, 2019

Presentation TVT 2019

2 Illustrative Cases – A Case-Based Discussion

Presenter: Helge Möllmann

June 13, 2019

Presentation TVT 2019

Design Characteristics, Clinical Data, and Future Vision

Presenter: Alexandre Abizaid

June 13, 2019

Presentation TVT 2019

2 Illustrative Cases – A Case-Based Discussion

Presenter: Helge Möllmann

June 13, 2019

Presentation TVT 2019

Design Characteristics, Clinical Data, and Future Vision

Presenter: Gregory Fontana

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Presenter: Christopher Meduri

June 13, 2019

Presentation TVT 2019

Advanced Design Features, Implantation Tips and Tricks, and Future Vision

Presenter: Didier Tchetche

June 13, 2019

Presentation TVT 2019

Conduction Block After TAVR: Do I Discharge Early, Monitor, Invasively Investigate, or Pace?

Presenter: David Wood

June 13, 2019

Presentation TVT 2019

New Conduction Abnormalities (Especially LBBB) After TAVR. Do They Matter?

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

Presenter: Josep Rodés-Cabau

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Managing Severe AV/LVOT Calcification, and Coronary Access Issues) – A Case-Based Discussion

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Preliminary Data on Hemodynamic Outcomes After Sapien ULTRA

Presenter: Rebecca Hahn

June 13, 2019

Advertisement

The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS Results

LAA Occlusion Plus: MitraClip, TAVR, PCI, and More

2 Illustrative Cases – A Case-Based Discussion

Better for Bicuspids and Dry Leaflet Technology

Which Patients Should Still Have Surgical AVR? Who Are Poor Candidates for TAVR?

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Does Surgical Risk Still Matter When Evaluating for TAVR?

The LOTUS Edge TAVR System: Clinical Trial Updates

2 Illustrative Cases – A Case-Based Discussion

Design Characteristics, Clinical Data, and Future Vision

2 Illustrative Cases – A Case-Based Discussion

Design Characteristics, Clinical Data, and Future Vision

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Advanced Design Features, Implantation Tips and Tricks, and Future Vision

Conduction Block After TAVR: Do I Discharge Early, Monitor, Invasively Investigate, or Pace?

New Conduction Abnormalities (Especially LBBB) After TAVR. Do They Matter?

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

3 Illustrative Cases (Optimal Valve Sizing, Managing Severe AV/LVOT Calcification, and Coronary Access Issues) – A Case-Based Discussion

Preliminary Data on Hemodynamic Outcomes After Sapien ULTRA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content